- A new national survey reveals considerable differences between psychiatrists’ perceptions about the safety and therapeutic value of certain psychoactive drugs and how those same drugs are categorized under U.S. policy. Drugs evaluated in the study: psilocybin, ketamine, methamphetamine, alprazolam. https://news.osu.edu/psychiatrists-disagree-with-us-policy-on-psychoactive-drugs/ 18 comments science
Linked pages
Related searches:
Search whole site: site:news.osu.edu
Search title: Psychiatrists disagree with U.S. policy on psychoactive drugs
See how to search.